BACKGROUND: Angiogenesis plays important roles in pathogenesis in human cancer. We assessed the relationship between clinical features of renal cell cancer (RCC) and PlGF levels in relation to VEGF. MATERIALS AND METHODS: Plasma PlGF and VEGF levels were measured in patients with renal cell cancer. The levels of these angiogenetic factors were analyzed in relation to clinical parameters. RESULTS: PlGF and VEGF levels in patients with RCC were significantly higher than those in non-cancer controls. PlGF levels were significantly associated with histological grade and total tumor vascularity (TTV), and VEGF levels were significantly associated with T, M stage, histological grade, venous invasion and TTV. Multivariate analysis showed plasma PlGF was an independent prognostic factor. CONCLUSION: These findings suggested that plasma PlGF levels were significantly associated with the clinical features of RCC, especially prognostic significance.
BACKGROUND: Angiogenesis plays important roles in pathogenesis in humancancer. We assessed the relationship between clinical features of renal cell cancer (RCC) and PlGF levels in relation to VEGF. MATERIALS AND METHODS: Plasma PlGF and VEGF levels were measured in patients with renal cell cancer. The levels of these angiogenetic factors were analyzed in relation to clinical parameters. RESULTS:PlGF and VEGF levels in patients with RCC were significantly higher than those in non-cancer controls. PlGF levels were significantly associated with histological grade and total tumor vascularity (TTV), and VEGF levels were significantly associated with T, M stage, histological grade, venous invasion and TTV. Multivariate analysis showed plasma PlGF was an independent prognostic factor. CONCLUSION: These findings suggested that plasma PlGF levels were significantly associated with the clinical features of RCC, especially prognostic significance.
Authors: H M C Shantha Kumara; Jenny C Cabot; Xiaohong Yan; Sonali A C Herath; Martin Luchtefeld; Matthew F Kalady; Daniel L Feingold; Raymond Baxter; Richard L Whelan Journal: Surg Endosc Date: 2010-12-24 Impact factor: 4.584
Authors: Femke Heindryckx; Koen Mertens; Nicolas Charette; Bert Vandeghinste; Christophe Casteleyn; Christophe Van Steenkiste; Dominique Slaets; Louis Libbrecht; Steven Staelens; Peter Starkel; Anja Geerts; Isabelle Colle; Hans Van Vlierberghe Journal: Mol Cancer Date: 2010-08-20 Impact factor: 27.401
Authors: Monika Magdalena Żyła; Marta Kostrzewa; Ewelina Litwińska; Artur Szpakowski; Jacek Radosław Wilczyński; Tomasz Stetkiewicz Journal: Prz Menopauzalny Date: 2014-05-21
Authors: Christopher H Lieu; Hai Tran; Zhi-Qin Jiang; Muling Mao; Michael J Overman; E Lin; Cathy Eng; Jeffrey Morris; Lee Ellis; John V Heymach; Scott Kopetz Journal: PLoS One Date: 2013-10-15 Impact factor: 3.240